Skip to content
2000
Volume 13, Issue 7
  • ISSN: 1570-1808
  • E-ISSN: 1875-628X

Abstract

A series of 6-diethylaminoquinazolin-4(3H)-ones with bulky aryl rings at C2 were designed to cover the vacant space of ligand binding pocket of topoisomerase (topo) I-DNA complex. The desired derivatives were synthesized by thermal cyclodehydration/ dehydrogenation reactions of 5-diethylaminoanthranilamide with substituted aromatic aldehydes. The cytotoxicity of these compounds was evaluated against human epidermoid carcinoma (KB), hepatocellular carcinoma (Hep-G2), human lung carcinoma (LU-1) and human breast carcinoma cells (MCF-7). Most of the synthesized compounds exhibited more potent cytotoxicity than the standard anticancer agent, ellipticine. Among the tested compounds, quinazolinone 1l was the most cytotoxic against all cancer cell lines (IC50: 0.02–0.08 μM). Docking study showed that the new 2-aryl-6- diethylaminoquinazolinones possibly inhibit topo I activities to exhibit anticancer properties.

Loading

Article metrics loading...

/content/journals/lddd/10.2174/1570180813666160125222936
2016-08-01
2025-07-12
Loading full text...

Full text loading...

/content/journals/lddd/10.2174/1570180813666160125222936
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test